These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Can prognostic factors assist therapeutic decisions in idiopathic membranous nephropathy? Ponticelli C; Passerini P J Nephrol; 2010; 23(2):156-63. PubMed ID: 20213607 [TBL] [Abstract][Full Text] [Related]
27. Cyclosporine A in treatment of membranous lupus nephropathy. Hu W; Liu Z; Shen S; Li S; Yao X; Chen H; Li L Chin Med J (Engl); 2003 Dec; 116(12):1827-30. PubMed ID: 14687467 [TBL] [Abstract][Full Text] [Related]
28. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy. Heeringa SF; Branten AJ; Deegens JK; Steenbergen E; Wetzels JF Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739 [TBL] [Abstract][Full Text] [Related]
29. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience. El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303 [TBL] [Abstract][Full Text] [Related]
30. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome. Alexopoulos E; Papagianni A; Tsamelashvili M; Leontsini M; Memmos D Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719 [TBL] [Abstract][Full Text] [Related]
31. Intravenous immunoglobulin therapy of membranous nephropathy: efficacy and safety. Palla R; Cirami C; Panichi V; Bianchi AM; Parrini M; Grazi G Clin Nephrol; 1991 Mar; 35(3):98-104. PubMed ID: 2032403 [TBL] [Abstract][Full Text] [Related]
32. Immunosuppressive treatment of the glomerulonephritis of systemic lupus. Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy. Idasiak-Piechocka I; Oko A; Łochyńska-Bielecka K; Skrobańska B Kidney Blood Press Res; 2009; 32(4):263-7. PubMed ID: 19776643 [TBL] [Abstract][Full Text] [Related]
34. Long-term outcome of adult patients with minimal urinary abnormalities and normal renal function. Shu KH; Ho WL; Lu YS; Cheng CH; Wu MJ; Lian JD Clin Nephrol; 1999 Jul; 52(1):5-9. PubMed ID: 10442489 [TBL] [Abstract][Full Text] [Related]
35. The impact of sex in primary glomerulonephritis. Cattran DC; Reich HN; Beanlands HJ; Miller JA; Scholey JW; Troyanov S; Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409 [TBL] [Abstract][Full Text] [Related]
36. Membranous nephropathy: a 19 year prospective study in 51 patients. Hay NM; Bailey RR; Lynn KL; Robson RA N Z Med J; 1992 Dec; 105(947):489-91. PubMed ID: 1461605 [TBL] [Abstract][Full Text] [Related]
37. Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial. Hofstra JM; Branten AJ; Wirtz JJ; Noordzij TC; du Buf-Vereijken PW; Wetzels JF Nephrol Dial Transplant; 2010 Jan; 25(1):129-36. PubMed ID: 19666912 [TBL] [Abstract][Full Text] [Related]